Lakewood-Amedex Biotherapeutics Inc. Common Stock
LABTRank #117Updated . Prices are snapshots and may be delayed.
Lakewood-Amedex Biotherapeutics Inc. Common Stock price chart
AI Outlook for Lakewood-Amedex Biotherapeutics Inc. Common Stock
Neutral posture- Medium-term trend-80.4% vs 50-day average
- 30-day momentum-86.0%
- RSI (14)18
- 1 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Lakewood-Amedex Biotherapeutics Inc. Common Stock performance
About Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc. Common Stock is a biotechnology company based in the United States, listed on NASDAQ since 2026 (ticker LABT).
Its market capitalisation is $1 million, the #117 largest of the 122 stocks Air Radar has market-cap data for.
Lakewood-Amedex Biotherapeutics Inc. Common Stock market data
What is the price of Lakewood-Amedex Biotherapeutics Inc. Common Stock today?
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) is at $0.31, −10.48% on the day.
What is the 52-week range of Lakewood-Amedex Biotherapeutics Inc. Common Stock?
Over the past year Lakewood-Amedex Biotherapeutics Inc. Common Stock has traded between $0.4216 and $98.20. It is currently -0% of the way up that range.
What is the market cap of Lakewood-Amedex Biotherapeutics Inc. Common Stock?
Lakewood-Amedex Biotherapeutics Inc. Common Stock has a market capitalisation of $1,159,962, the #117 largest of the stocks Air Radar has market-cap data for.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.